Chemours Co (CC)
Official siteBASIC MATERIALS • SPECIALTY CHEMICALS • NYSE
Market Cap: $2.00B
Last updated: Nov 17, 2026 at 4:16 PM ET
Chemours Co (CC) Statistics
Chemours (CC) has a market cap of $2.00B and an enterprise value of $5.14B. Its net debt of $3.13B equals 156.72% of its market cap. Its trailing P/E of 16.7x is above its 10-year median of 11.0x.
Total Valuation
Enterprise value is 156.72% above the market cap, as debt exceeds cash.
| Market Cap | $2.00B |
|---|---|
| Enterprise Value | $5.14B |
| Latest price (Nov 17, 2026) | $12.18 |
Key Dates
The next earnings report is expected on Feb 17, 2027, covering the quarter ending Dec 31, 2026. The last ex-dividend date was Nov 16, 2026.
| Next Earnings Date | Feb 17, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 2, 2026 |
| Last Ex-Dividend Date | Nov 16, 2026 |
| Next Payment Date | Dec 15, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 0.3x and 11.8x. Its year-end P/E ranged from 5.0x to 21.7x from 2016 to 2025.
| P/E Ratio | 16.7x |
|---|---|
| Forward P/E | 13.8x |
| P/S Ratio | 0.3x |
| Forward P/S | 0.3x |
| P/B Ratio | 11.8x |
| P/TBV Ratio | 17.1x |
| P/FCF Ratio | 8.7x |
| P/OCF Ratio | 5.0x |
| PEG Ratio | 0.5 |
Enterprise Valuation
Counting debt and cash, the company is valued at 6.9x EBITDA and 23.5x free cash flow.
| EV / Sales | 0.9x |
|---|---|
| EV / EBITDA | 6.9x |
| EV / EBIT | 13.3x |
| EV / FCF | 23.5x |
Price Statistics
The stock is up 3.28% over 52 weeks and trades 10.04% below its 50-day average.
| Beta (1Y) | 1.41 |
|---|---|
| 52-Week Change | +3.28% |
| 1-Month Change | -2.85% |
| 3-Month Change | -22.94% |
| 6-Month Change | -43.71% |
| 5-Year Change | -51.71% |
| 10-Year Change | -17.65% |
| Total Return (1Y) | +6.25% |
| Total Return (3Y CAGR) | -21.26% |
| Total Return (5Y CAGR) | -14.98% |
| Return vs SPY (1Y) | +0.79% |
| Max Drawdown (1Y) | -56.02% |
| Max Drawdown (3Y) | -69.02% |
| Sharpe Ratio (1Y) | 0.19 |
| Correlation with SPY (1Y) | 0.32 |
| 50-Day Average | $13.54 |
| 200-Day Average | $18.11 |
| 52-Week Range | $10.22 to $28.22 |
| RSI (14 Days) | 37.5 |
| Average Volume (20 Days) | 2.45M |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 1.81x current liabilities, and total debt is 24.73x shareholder equity.
| Current Ratio | 1.81x |
|---|---|
| Quick Ratio | 0.98x |
| Debt / Equity | 24.73x |
| Debt / EBITDA | 5.36x |
| Debt / FCF | 18.17x |
| Interest Coverage | 1.33x |
Returns and Efficiency
Return on invested capital is 6.28% over the last 12 months, against a 5-year average of 6.11%.
| Return on Equity (ROE) | -109.03% |
|---|---|
| Return on Assets (ROA) | -2.32% |
| Return on Invested Capital (ROIC) | 6.28% |
| Return on Capital Employed (ROCE) | 6.98% |
| ROE (5Y Average) | -13.76% |
| ROA (5Y Average) | 1.65% |
| ROIC (5Y Average) | 6.11% |
| Asset Turnover | 0.79x |
| Inventory Turnover | 3.39x |
| Receivables Turnover | 6.39x |
| Cash Conversion Cycle | 94 days |
Scores
CC has an Altman Z-Score of 1.57, in the distress zone below 1.81, and a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 1.57 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 4 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $5.84B over the last 12 months is up 0.10% from the 12 months before.
| Revenue | $5.84B |
|---|---|
| Revenue Growth (YoY) | +0.10% |
| Gross Profit | $884.00M |
| Operating Income | $36.00M |
| Pretax Income | $132.00M |
| Net Income | -$169.00M |
| EBITDA | $715.00M |
| EBIT | $385.00M |
| Reported EPS (TTM) | $0.73 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 2.13% of the $7.29B in total assets.
| Cash and Equivalents | $698.00M |
|---|---|
| Total Debt | $3.83B |
| Net Debt | $3.13B |
| Net Debt Per Share | $20.83 |
| Working Capital | $1.44B |
| Shareholder Equity | $155.00M |
| Book Value Per Share | $1.03 |
| Tangible Book Value | $107.00M |
| Tangible Book Per Share | $0.71 |
| Total Assets | $7.29B |
| Total Liabilities | $7.14B |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $189.00M of capital spending, operating cash flow left $211.00M of free cash flow.
| Operating Cash Flow | $400.00M |
|---|---|
| Capital Expenditures | $189.00M |
| Free Cash Flow | $211.00M |
| FCF Per Share | $1.40 |
| Depreciation and Amortization | $330.00M |
| Dividends Paid | $54.00M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 0.62%, against a 5-year average of 4.47%.
| Gross Margin | 15.13% |
|---|---|
| Operating Margin | 0.62% |
| Pretax Margin | 2.26% |
| Net Margin | -2.89% |
| EBITDA Margin | 12.24% |
| EBIT Margin | 6.59% |
| FCF Margin | 3.61% |
| Gross Margin (5Y Average) | 20.42% |
| Operating Margin (5Y Average) | 4.47% |
| Net Margin (5Y Average) | 1.69% |
Growth
Revenue fell 5.26% a year over 3 years, and EPS 37.56% a year.
| Revenue Growth (3Y CAGR) | -5.26% |
|---|---|
| Revenue Growth (5Y CAGR) | +3.17% |
| EPS Growth (3Y CAGR) | -37.56% |
| EPS Growth (5Y CAGR) | -13.48% |
| FCF Growth (3Y CAGR) | -51.53% |
| FCF Growth (5Y CAGR) | -37.62% |
Dividends and Yields
CC pays out 76.36% of earnings as dividends.
| Dividend Per Share (Annual) | $0.35 |
|---|---|
| Dividend Yield | 2.87% |
| Payment Schedule | Quarterly |
| Dividend Growth (3Y CAGR) | -19.97% |
| Dividend Growth (5Y CAGR) | -12.51% |
| Payout Ratio | 76.36% |
| FCF Payout Ratio | 25.59% |
| Earnings Yield | 5.99% |
| FCF Yield | 11.51% |
| Buyback Yield | 0.00% |
| Shareholder Yield | 2.95% |
Peer Position
Against 11 similar companies, CC has the 6th highest P/E.
P/E RatioPeer median 15.3x
P/S RatioPeer median 1.1x
ROICPeer median 6.32%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +8.27%
Dividend YieldPeer median 1.62%
| P/E Ratio | 16.7x vs 15.3x median |
|---|---|
| P/S Ratio | 0.3x vs 1.1x median |
| ROIC | 6.28% vs 6.32% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +0.10% vs +8.27% median |
| Dividend Yield | 2.87% vs 1.62% median |
Analyst Forecast
Consensus estimates put revenue growth at 2.79% and EPS growth at 33.98% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +2.79% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | +33.98% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About CC
What is CC's market cap?
Chemours has a market cap of $2.00B. Its enterprise value, which adds debt and subtracts cash, is $5.14B.
What is CC's P/E ratio?
Chemours has a trailing P/E ratio of 16.7x and a forward P/E of 13.8x.
How many shares of CC are outstanding?
Chemours has 150.53M shares outstanding. The count is up 0.43% from a year earlier.
Does CC pay a dividend?
Yes. Chemours pays $0.35 a share a year, a dividend yield of 2.87%.
How much debt does CC have?
Chemours has $3.83B of total debt and $698.00M of cash and equivalents, a net debt position of $3.13B.
CC pages: Overview, Dividends, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors